(Q34198656)

31 July 2017

title

The role of the TSC-22 (-396) A/G variant in the development of diabetic nephropathy (English)

1 reference

31 July 2017

Fumiaki Sugawara

1

1 reference

31 July 2017

Yuichiro Yamada

2

1 reference

31 July 2017

Rie Watanabe

3

1 reference

31 July 2017

Nobuhiro Ban

4

1 reference

31 July 2017

Kazumasa Miyawaki

5

1 reference

31 July 2017

Akira Kuroe

6

1 reference

31 July 2017

Akihiro Hamasaki

7

1 reference

31 July 2017

Hiroki Ikeda

8

1 reference

31 July 2017

Takeshi Kurose

9

1 reference

31 July 2017

Masaru Usami

10

1 reference

31 July 2017

Masaki Ikeda

11

1 reference

31 July 2017

Yutaka Seino

12

1 reference

31 July 2017

publication date

1 June 2003

1 reference

Diabetes Research and Clinical Practice

31 July 2017

published in

1 reference

31 July 2017

volume

60

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

191-197

1 reference

Renal disease and hypertension in non-insulin-dependent diabetes mellitus.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900038-X

7 January 2021

Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900038-X

7 January 2021

Cloning of the human homologue of the TGF beta-stimulated clone 22 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900038-X

7 January 2021

Human TSC-22 gene: no association with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900038-X

7 January 2021

Nifedipine and enalapril equally reduce the progression of nephropathy in hypertensive type 2 diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900038-X

7 January 2021

The MH1 domains of smad2 and smad3 are involved in the regulation of the ALK7 signals.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900038-X

7 January 2021

Renoprotection in diabetes: genetic and non-genetic risk factors and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900038-X

7 January 2021

Angiotensin converting enzyme inhibitor suppresses glomerular transforming growth factor beta receptor expression in experimental diabetes in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900038-X

7 January 2021

Association of transforming growth factor-beta1 T29C polymorphism with the progression of diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900038-X

7 January 2021

Expression of TGF-beta stimulated clone-22 (TSC-22) in mouse development and TGF-beta signalling.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900038-X

7 January 2021

The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900038-X

7 January 2021

Sp1 and Smad proteins cooperate to mediate transforming growth factor-beta 1-induced alpha 2(I) collagen expression in human glomerular mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900038-X

7 January 2021

10.1016/S0168-8227(03)00038-X

Identifiers

DOI

1 reference

31 July 2017

1 reference